PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,141,000 | -81.9% | 152,745 | -76.5% | 0.00% | -85.7% |
| Q2 2014 | $6,290,000 | +3.3% | 649,783 | -11.3% | 0.01% | 0.0% |
| Q1 2014 | $6,087,000 | -0.1% | 732,527 | +1.5% | 0.01% | 0.0% |
| Q4 2013 | $6,093,000 | +7.6% | 721,875 | +1.6% | 0.01% | 0.0% |
| Q3 2013 | $5,662,000 | +95.0% | 710,396 | +88.9% | 0.01% | +75.0% |
| Q2 2013 | $2,904,000 | – | 376,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |